Loading data for CDNA — first visit, this takes a few seconds.
CareDx Inc. (CDNA)
NasdaqGM: CDNA
· Real-Time Price · USD
52.36
+1.40 (2.75%)
At close: Aug 28, 2026, 8:00 PM
49.72
-0.14%
After-hours: 7:37 PM
The price, the headline numbers and the latest news, in one place.
CareDx Inc. (CDNA) Stock Price, Analysis & Data
2.75% (1D)
No data available
| Bid | 33.74 |
| Market Cap | 2.58B |
| Revenue (ttm) | 458.09M |
| Net Income (ttm) | 111.01M |
| 2.42 | |
| 2.08 | |
| 23.94 | |
| 36.75 | |
| P/B (ttm) | 6.02 |
| P/S (ttm) | 5.62 |
| Earnings Date | Nov 3, 2026 |
| Ask | 60.27 |
| Volume | 1,250,771 |
| Avg. Volume (20D) | 1,099,203 |
| Open | 51.00 |
| Previous Close | 50.96 |
| Day's Range | 50.77 - 53.67 |
| 52-Week Range | 12.37 - 53.67 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CDNA
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA so...
Industry Diagnostics & Research
Sector Healthcare
IPO Date Jul 17, 2014
Employees 761
Stock Exchange NasdaqGM
Ticker Symbol CDNA
Website https://caredx.com
Financial Performance
In 2025, CareDx's revenue was 379.81M, an increase of 13.79% compared to the previous year's 333.79M. Earnings were -21.35M, a decrease of -140.64%.
Financial StatementsEarnings Surprise
CareDx has released their quarterly earnings on Jul 30, 2026:
- Revenue of $131.95M misses estimates by $0, with 52.23% YoY growth.
- EPS of 0.37 exceeds estimates by 0.14, with 270.00% YoY growth.
CareDx Inc. is scheduled to release its earnings on Nov 3, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2